1. Gu, Yanan, Wu, Shiqi, Fan, Junjie, Wang, Xinyang, Wu, Kaijie. 2024. CYLD regulates cell ferroptosis through Hippo/YAP signaling in prostate cancer progression. In Cell death & disease, 15, 79. doi:10.1038/s41419-024-06464-5. https://pubmed.ncbi.nlm.nih.gov/38246916/
2. Zhu, Guixin, Herlyn, Meenhard, Yang, Xiaolu. 2021. TRIM15 and CYLD regulate ERK activation via lysine-63-linked polyubiquitination. In Nature cell biology, 23, 978-991. doi:10.1038/s41556-021-00732-8. https://pubmed.ncbi.nlm.nih.gov/34497368/
3. Zhan, Yongqiang, Xu, Dongwei, Tian, Yizhu, Farmer, Douglas G, Ke, Bibo. 2022. Novel role of macrophage TXNIP-mediated CYLD-NRF2-OASL1 axis in stress-induced liver inflammation and cell death. In JHEP reports : innovation in hepatology, 4, 100532. doi:10.1016/j.jhepr.2022.100532. https://pubmed.ncbi.nlm.nih.gov/36035360/
4. Dobson-Stone, Carol, Hallupp, Marianne, Shahheydari, Hamideh, Blair, Ian P, Kwok, John B. . CYLD is a causative gene for frontotemporal dementia - amyotrophic lateral sclerosis. In Brain : a journal of neurology, 143, 783-799. doi:10.1093/brain/awaa039. https://pubmed.ncbi.nlm.nih.gov/32185393/
5. Blake, Patrick W, Toro, Jorge R. . Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling. In Human mutation, 30, 1025-36. doi:10.1002/humu.21024. https://pubmed.ncbi.nlm.nih.gov/19462465/